Amcor has launched a proprietary healthcare lidding technology suited for combination products (those consisting of two or more regulated components such as a device, drug, or biologic). Based on a patented inert film development and laminate design, the new lidding can withstand heat sterilization, while preventing drug uptake into the packaging, the company reported in a news release.
Amcor collaborated with Johnson & Johnson Vision over the course of several years to develop the lidding technology for use with contact lenses. Amcor provided expertise with film extrusion, lamination, and conversion for healthcare, while J&J Vision provided expertise on ophthalmic device packaging requirements, according to the release.
“We are bringing together industry-leading innovation and close customer relationships to develop the packaging solutions of the future," stated Peter Konieczny, Amcor’s chief commercial officer. "With this next-generation healthcare lidding technology we are opening a world of possibilities for products using active pharma ingredients. We look forward to extending this differentiated lidding technology to additional combination products in the future.”
The solution offers machinability, integrity after sterilization, and a convenient peel opening for patients. The features of the new product complement Amcor’s existing healthcare portfolio, which range from lidding for demanding sterilization environments to high-barrier overwraps protecting eye droppers and medications for the eye, the company reported.